KRAS mutations of the lung adenocarcinoma genome and their impact on inflammation
- Weitere Titel
-
KRAS Mutationen im Genom von Adenokarzinomzellen der Lunge und deren Einfluß auf Inflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Habilitationsschrift, 2021
- Schlagwort
-
Lungs
Adenocarcinoma
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.5282/edoc.28156
- URN
-
urn:nbn:de:bvb:19-281378
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Stathopoulos, Georgios
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations
RIPK3 suppresses Kras-driven pulmonary adenoma and adenocarcinoma formation
KRAS mutations in squamous cell carcinomas of the lung
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Inhibition of MCL-1 blocks the development of KRAS-driven adenocarcinoma of the lung
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Genome-wide mapping of the inflammation methylome
"KRAS
Kras
Author correction: Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations
RIPK3 suppresses Kras-driven pulmonary adenoma and adenocarcinoma formation
KRAS mutations in squamous cell carcinomas of the lung
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Inhibition of MCL-1 blocks the development of KRAS-driven adenocarcinoma of the lung
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Genome-wide mapping of the inflammation methylome
"KRAS
Kras
Author correction: Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
DV-47/19.- Ersatzteilkatalog für die Kraftfahrzeuge KRAS-214, KRAS-219, KRAS-221 und KRAS-222
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations
RIPK3 suppresses Kras-driven pulmonary adenoma and adenocarcinoma formation
KRAS mutations in squamous cell carcinomas of the lung
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations
Inhibition of MCL-1 blocks the development of KRAS-driven adenocarcinoma of the lung
Regulation and therapeutic targeting of MTHFD2 and EZH2 in KRAS mutated human pulmonary adenocarcinoma
Genome-wide mapping of the inflammation methylome
"KRAS
Kras
Author correction: Pancreatic cancer: circulating tumor cells and primary tumors show heterogeneous KRAS mutations